Contents
pdf Download PDF pdf Download XML
76 Views
19 Downloads
Share this article
Research Article | Volume 2 Issue 4 (None, 2008) | Pages 49 - 51
Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis
 ,
Under a Creative Commons license
Open Access
PMID : PMC3157784
Received
Oct. 30, 2008
Published
Dec. 27, 2008
Abstract

Background:Abatacept is a soluble fusion protein approved as add-on drug in rheumatoid arthritis.Main observations:Here we report the first case of fixed drug eruption followed by lichen aureus due to abatacept in a 67-year-old woman.Conclusion:Fixed drug eruption is an unexpected drug reaction for abatacept, since T-cell activation is inhibited.

Keywords
Recommended Articles
Research Article
Impact of COVID-19 on Sexually Transmitted Infection Burden: A Cross-Sectional Study from a Tertiary Care Hospital in Gujarat
...
Published: 02/08/2025
Original Article
An analysis of Morphometric characteristics of Supratrochlear foramen of humerus
Published: 08/06/2025
Original Article
Outcomes of Plastic Surgical Reconstruction of Diabetic Foot Ulcers Following Systemic Optimization and Local Infection Control: A Prospective Study
...
Published: 08/06/2025
Research Article
Comparative Study of Oral Levamisole versus Oral Betamethasone in Vitiligo: A Prospective Analysis.
...
Published: 28/06/2025
© Copyright Spejalisci Dermatolodzy